Anti-Cancer Drug Delivery Agents

Most explored approaches to developing cell-based Anti Cancer drug delivery systems (DDSs) are encapsulation of the drug into the cells, cell surface modification, genetic modification of cells to secrete desired therapeutic proteins, and generating new biosynthetic systems. Tumor-tropism of mesenchymal stem cells (MSCs), as reveal in many studies, can be incorporate with expropriate engineering with anticancer genes to authorize their utilization in anticancer therapy. Furthermore, MSCs can be filled with nanoparticles (NPs), procure transport across the blood-brain barrier and accumulation of anticancer agent at the tumour site


    Related Conference of Anti-Cancer Drug Delivery Agents

    March 18-19, 2024

    20th International Conference on Cancer Research

    Zurich, Switzerland
    April 24-25, 2024

    33rd Neonatology and Primary Care Congress

    Paris, France
    July 25-26, 2024

    20th World Summit on Blockchain Technology

    Amsterdam, Netherlands

    Anti-Cancer Drug Delivery Agents Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in